Daniel Lynch, Director: SpringWorks Therapeutics SWTX Sell · Filed 25/02/12

Trade details

Type: Insider sale
Amount: $3,713,644.18
Shares · price: 69,766 sh · $53.23 a share
Held after: 236,178 sh
Stock: SpringWorks Therapeutics SWTX
Person: Daniel LynchDirector
Trade date: 25/02/10
Filed: 25/02/12
Days to filing: 2 days

Sold 22.8% of holdings

Share of holding sold: 22.8%

SpringWorks Therapeutics trades, last 26 weeks

What else happened in SpringWorks Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/11~25/03/12

Daniel Lynch's recent trades

Daniel LynchDirector
Sell10b5-1 planSpringWorks Therapeutics
Sell10b5-1 plan
SpringWorks Therapeutics
SWTX
$2.6M
44,018 sh
$2.6M
Filed 25/02/24
Traded 25/02/20
Daniel LynchDirector
Sell10b5-1 planSpringWorks Therapeutics
Sell10b5-1 plan
SpringWorks Therapeutics
SWTX
$219.4K
3,582 sh
$219.4K
Filed 25/02/24
Traded 25/02/20
Daniel LynchDirector
Sell10b5-1 planSpringWorks Therapeutics
Sell10b5-1 plan
SpringWorks Therapeutics
SWTX
$24K
400 sh
$24K
Filed 25/02/19
Traded 25/02/14
Daniel LynchDirector
Sell10b5-1 planSpringWorks Therapeutics
Sell10b5-1 plan
SpringWorks Therapeutics
SWTX
$3.6M
65,600 sh
$3.6M
Filed 25/02/12
Traded 25/02/10
Daniel LynchDirector
Sell10b5-1 planSpringWorks Therapeutics
Sell10b5-1 plan
SpringWorks Therapeutics
SWTX
$2.2M
39,634 sh
$2.2M
Filed 25/02/12
Traded 25/02/10